TRASTUZUMAB DERUXTECAN
Clinical trials for TRASTUZUMAB DERUXTECAN explained in plain language.
Never miss a new study
Get alerted when new TRASTUZUMAB DERUXTECAN trials appear
Sign up with your email to follow new studies for TRASTUZUMAB DERUXTECAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can switching breast cancer drugs improve outcomes? new study watches real-world results.
Knowledge-focused Recruiting nowThis study observes 100 people in Korea with advanced HER2-positive breast cancer who take a drug called T-DM1 right after another drug, T-DXd, stops working. Researchers will track how long the cancer stays controlled and how well patients respond. The goal is to learn if this d…
Matched conditions: TRASTUZUMAB DERUXTECAN
Sponsor: Seoul National University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study checks how well a targeted breast cancer drug works in russian patients
Knowledge-focused Recruiting nowThis study will look at medical records of 60 Russian patients with advanced HER2-positive breast cancer who have received trastuzumab deruxtecan. Researchers want to see how long the drug keeps cancer from growing and how safe it is. The goal is to understand how well this treat…
Matched conditions: TRASTUZUMAB DERUXTECAN
Phase: NA • Sponsor: Blokhin's Russian Cancer Research Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC